Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma
Clinical trial NCT03201250 · TERMINATED
Trial details
- NCT number
- NCT03201250
- Sponsor
- University of Nebraska
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-21
- Primary completion
- 2021-04-12
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.